Data as of 4:01pm ET
| +0.09 / +9.47%|
The 3 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 5.00, with a high estimate of 5.50 and a low estimate of 3.00. The median estimate represents a +380.77% increase from the last price of 1.04.
The current consensus among 3 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.